CaMKP Inhibitor 10 mg | 96.55%
TargetMol
CaMKP Inhibitor
Search Results
Temsirolimus 50 mg | 97.69%
TargetMol
Temsirolimus is a specific mTOR inhibitor ( IC50: 1.76 μM), used in the treatment of advanced renal cell cancer.
More Information Supplier PageTemsirolimus
Temsirolimus 25 mg | 97.69%
TargetMol
Temsirolimus is a specific mTOR inhibitor ( IC50: 1.76 μM), used in the treatment of advanced renal cell cancer.
More Information Supplier PageTemsirolimus
Temsirolimus 10 mg | 97.69%
TargetMol
Temsirolimus is a specific mTOR inhibitor ( IC50: 1.76 μM), used in the treatment of advanced renal cell cancer.
More Information Supplier PageTemsirolimus
Temsirolimus 100 mg | 97.69%
TargetMol
Temsirolimus is a specific mTOR inhibitor ( IC50: 1.76 μM), used in the treatment of advanced renal cell cancer.
More Information Supplier PageTemsirolimus
CaMKP Inhibitor 50 mg | 96.55%
TargetMol
CaMKP Inhibitor
CaMKP Inhibitor 5 mg | 96.55%
TargetMol
CaMKP Inhibitor
2-(1,8-naphthyridin-2-yl)phenol 25 mg | 99.84%
TargetMol
2-(1,8-naphthyridin-2-yl)phenol
2-(1,8-naphthyridin-2-yl)phenol 10 mg | 99.84%
TargetMol
2-(1,8-naphthyridin-2-yl)phenol
Cardiogenol C 5 mg | Purity Not Available
TargetMol
Cardiogenol C
